Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Patient with Neuromyelitis Optica Spectrum Disorder Combined with Sjögren's Syndrome Relapse Free Following Tacrolimus Treatment.
Comparison between the cranial magnetic resonance imaging features of neuromyelitis optica spectrum disorder versus multiple sclerosis in Taiwanese patients.
High-affinity sigma-1 protein agonist reduces clinical and pathological signs of experimental auto-immune encephalomyelitis.
A Model of Population and Subject (MOPS) Intensities with Application to Multiple Sclerosis Lesion Segmentation.
Follow-up nerve conduction studies in CIDP after treatment with IGIV-C: Comparison of patients with and without subsequent relapse.
[Clinical and epidemiological aspects of multiple sclerosis in the Moscow region.]
Interferon-β-1a-induced psychosis in a patient with multiple sclerosis.
[Multiple sclerosis and peripheral neuropathy].
Paroxetine-Related Adult-Onset Tic Disorder: A Presentation of Primary Progressive Multiple Sclerosis.
Live-Imaging in the CNS: New Insights on Oligodendrocytes, Myelination, and their Responses to Inflammation.
SOX17 is expressed in regenerating oligodendrocytes in experimental models of demyelination and in multiple sclerosis.
Will Biomarkers Determine What Is Next in Multiple Sclerosis?: Biomarkers in Multiple Sclerosis.
Gait variability and multiple sclerosis.
Role of STIM-dependent Ca(2+) Influx in Regulatory B Cells.
CSF oligoclonal bands are important in the diagnosis of multiple sclerosis, unreasonably downplayed by the McDonald Criteria 2010: No.
Available evidence and outcome of off-label use of rituximab in clinical practice.
Ascl1/Mash1 Promotes Brain Oligodendrogenesis during Myelination and Remyelination.
Management of multiple sclerosis in adolescents - current treatment options and related adherence issues.
Participation of interleukin 17A in neuroimmune interactions.
Histological correlation of diffusional kurtosis and white matter modeling metrics in cuprizone-induced corpus callosum demyelination.
Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron.
Fingolimod attenuates splenocyte-induced demyelination in cerebellar slice cultures.
Novartis MS pill heads stream of SMC approvals
The possible efficacy of artichoke in fluconazole related hepatotoxicity.
No evidence for a role of rare CYP27B1 variants in Austrian multiple sclerosis patients.
Pages
« first
‹ previous
…
384
385
386
387
388
389
390
391
392
…
next ›
last »